NorthWest Biotherapeutics Inc (NWBO)

[Roman516]

The real truth of the DCVax-L matter

Not true
"DCVax-L is NOT the standard of care in Dr. Liau's SPORE Keytruda/ATL combination trial -- it is the comparator arm."

True
DCVax-L is the base product for the standard of care in Dr. Liau's SPORE Keytruda/ATL combination trial -- it is the comparator arm.

So, you agree that DCVax-L will in fact be used in the standard of care, and this "Treatment has been accepted by a number of medical experts as a proper treatment for a certain type of cancer disease and that it is the desire to be widely used by healthcare professionals."

DCVax-L works and should be approved so it can be the standard of care. Clear enough? Yes indeed, thanks for the real clarification.